To explore the possibility of targeting HLA-E as a means to enhance cellular therapy, we endeavored to define associations with HLA-E RNA expression from Beat AML dataset with ELN risk, genetic subtype and FAB status. The gene discussed is HLA-E; the disease is acute myeloid leukemia.